Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15410 total
PLCE heads into the final day of April with one of the most compressed short structures in retail — and a stock that just shed 10% on the week, closing at $3.22. Short sellers have been actively covering over the past…
CVR — Chicago Rivet & Machine Co. — is trading at $11.80 after a sharp 10% week-on-week recovery, and the catalyst is clear: the company's full-year results, released April 21-22, showed a dramatically narrowed net…
CVX heads into its Q1 2026 results on May 1 with a telling divergence: the Street has been lifting targets through a month that knocked the stock down more than 10%. The analyst move has been notably one-directional.…
Chesapeake Utilities enters its May 6 Q1 earnings call having quietly shrugged off the broader market turbulence of April — the stock gained 2.4% on the week to close at $127.47, broadly in line with peers across the…
Cheniere Energy approaches its May 7 Q1 print having recovered nearly 3% on the week to $264.98 — yet the stock remains down 11% from its month-ago highs, leaving a meaningful gap between where it trades and where…
Chemung Financial Corporation has had a remarkable April: a 26% monthly gain, an explosive post-earnings session, and a sharp pullback in short interest — all while the analyst consensus still barely clears the current…
CAKE heads into its May 28 earnings date with short interest at a six-week high and options traders the most bullish they've been all year. Short sellers have been rebuilding positions aggressively. SI jumped roughly…
Charles River Laboratories drops into its May 6 earnings call with a mixed but charged setup: short interest has climbed sharply over the past month, the stock is down nearly 9% on the week, and yet options traders…
Charles & Colvard, the moissanite jewellery maker trading on the OTC Pink market, is a stock defined more by its precarious standing than by any active short interest story — a sub-penny name with a market cap of…
Champions Oncology is the rare micro-cap where the most interesting development this week is not what bears are doing — it's what they have stopped doing in the options market, even as short positions quietly…
CBA — Champion Bear Resources Ltd. — is a micro-cap mining exploration stock trading at C$0.04 on the TSX Venture Exchange. The story this week is not price action. It is the near-vertical rise in short interest from a…
CERS reports Q1 2026 results after the close today — and the setup is unusually charged. A significant new supply contract sits alongside a recent cluster of insider selling, a short position that has grown materially…
Lumen Technologies reports Q1 results on May 5 carrying a 30% one-month gain, a week of flat action, and a put/call ratio that has nearly doubled from where it stood just two weeks ago. Options traders are the clearest…
Century Casinos heads into its May 8 Q1 earnings report with a striking divergence: options flow has turned decisively call-heavy at the same time the stock slips to $1.39, down 7% on the week. The clearest signal this…
Century Aluminum heads into its May 5 Q1 earnings report with a striking divergence: the stock is up 19% over the past month, yet insiders and its largest shareholder have spent March consistently selling into that…
Central Garden & Pet Company reports Q2 2026 results on May 6 — a week away — and the most interesting tension in the setup is the gap between a calm price action and a short position that has been quietly but steadily…
AXIA heads into its May 6 earnings with a striking split: insiders have been cashing out heavily into the stock's 17% monthly surge, while short sellers are quietly stepping back. The insider activity is the standout…
ConnectOne Bancorp enters the final stretch of April with its best monthly showing in some time — up 14% in April — and the Street's most active regional bank analyst just confirmed higher conviction on the…
CEMEX, S.A.B. de C.V. enters May having outperformed its global cement peers by a wide margin, with a strong Q1 earnings print behind it and the Street steadily moving targets higher — a notably different setup from…
Imunon enters the final stretch before its May 14 Q1 results with an unusually sharp contrast: a freshly initiated Buy rating and a $10 price target from Maxim Group against a stock trading at $2.75 — and a cash runway…
